Heathcote, E. Jenny

Publishing since 1994 (Senior)

Has published 120 publications in 17 years

Number of publications published per year by Heathcote, E. Jenny. (Source : PubMed)

Distribution of publications types for Heathcote, E. Jenny. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Pattullo V, Ravindran NC, Mazzulli T, Wong DK, Heathcote EJ. Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.  J. Viral Hepat.  2010  
•  Antaki N, Craxi A, Kamal S, Moucari R, Van der Merwe S, Haffar S, Gadano A, Zein N, Lai CL, Pawlotsky JM, Heathcote EJ, Dusheiko G, Marcellin P. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report.  Liver Int.  2009  
•  Murthy SK, Heathcote EJ, Nguyen GC. Impact of cirrhosis and liver transplant on maternal health during labor and delivery.  Clin. Gastroenterol. Hepatol.  2009;7;12  
•  Milkiewicz P, Buwaneswaran H, Coltescu C, Shums Z, Norman GL, Heathcote EJ. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.  Clin. Gastroenterol. Hepatol.  2009;7;12  
•  Thein HH, Yi Q, Heathcote EJ, Krahn MD. Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort.  J. Viral Hepat.  2009;16;11  
•  Buster EH, Flink HJ, Simsek H, Heathcote EJ, Sharmila S, Kitis GE, Gerken G, Buti M, de Vries RA, Verhey E, Hansen BE, Janssen HL. Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients.  Am. J. Gastroenterol.  2009;104;10  
•  John-Baptiste AA, Tomlinson G, Hsu PC, Krajden M, Heathcote EJ, Laporte A, Yoshida EM, Anderson FH, Krahn MD. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.  Am. J. Gastroenterol.  2009;104;10  
•  Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis.  Hepatology  2009;50;1  
•  Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, Gu X, Walker EJ, Jing K, Juran BD, Mason AL, Myers RP, Peltekian KM, Ghent CN, Coltescu C, Atkinson EJ, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.  N. Engl. J. Med.  2009;360;24  
•  Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.  Gastroenterology  2009;136;5  

[ See timeline ] [ See all publications ]